These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 10668104)

  • 61. Regulatory role of nitric oxide over hippocampal 5-HT release in vivo.
    Segieth J; Pearce B; Fowler L; Whitton PS
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):302-6. PubMed ID: 11284445
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.
    Dahlöf CG; Falk L; Risenfors M; Lewis CP
    Cephalalgia; 1998 Oct; 18(8):546-51. PubMed ID: 9827246
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of protein synthesis by activation of NMDA receptors in cultured retinal cells: a new mechanism for the regulation of nitric oxide production.
    Cossenza M; Cadilhe DV; Coutinho RN; Paes-de-Carvalho R
    J Neurochem; 2006 Jun; 97(5):1481-93. PubMed ID: 16606372
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Zolmitriptan reverses blink reflex changes induced during the migraine attack in humans.
    de Tommaso M; Guido M; Libro G; Sciruicchio V; Puca F
    Neurosci Lett; 2000 Jul; 289(1):57-60. PubMed ID: 10899408
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanisms of action of the 5-HT1B/1D receptor agonists.
    Tepper SJ; Rapoport AM; Sheftell FD
    Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355
    [TBL] [Abstract][Full Text] [Related]  

  • 66. NMDA receptor-mediated increase in cyclic GMP in the rat cerebellum in vivo is blocked by alaproclate and GEA-857.
    Hu PS; Ross SB
    Pharmacol Toxicol; 1997 Feb; 80(2):97-102. PubMed ID: 9060041
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of presynaptic 5-hydroxytryptamine1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices.
    Raiteri M; Maura G; Barzizza A
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1184-8. PubMed ID: 1675289
    [TBL] [Abstract][Full Text] [Related]  

  • 68. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
    Bouchelet I; Case B; Olivier A; Hamel E
    Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of N-methyl-D-aspartic acid-nitric oxide synthase in rat hippocampal slices by ethanol. Evidence for the involvement of tetrahydrobiopterin but not lipid peroxidation.
    Czapski GA; Sun GY; Strosznajder JB
    J Biomed Sci; 2002; 9(1):3-9. PubMed ID: 11810019
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Zolmitriptan--a 5-HT1B/D agonist, alcohol, and aggression in mice.
    de Almeida RM; Nikulina EM; Faccidomo S; Fish EW; Miczek KA
    Psychopharmacology (Berl); 2001 Sep; 157(2):131-41. PubMed ID: 11594437
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The NO-cGMP pathway in neonatal rat dorsal horn.
    Morris R; Southam E; Gittins SR; de Vente J; Garthwaite J
    Eur J Neurosci; 1994 May; 6(5):876-9. PubMed ID: 7521251
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo.
    Bhardwaj A; Sawada M; London ED; Koehler RC; Traystman RJ; Kirsch JR
    Stroke; 1998 Nov; 29(11):2404-10; discussion 2411. PubMed ID: 9804655
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NMDA-mediated activation of the NO/cGMP pathway: characteristics and regulation in cultured neocortical neurones.
    Carroll FY; Beart PM; Cheung NS
    J Neurosci Res; 1996 Mar; 43(5):623-31. PubMed ID: 8833097
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low nanomolar serotonin inhibits the glutamate receptor/nitric oxide/cyclic GMP pathway in slices from adult rat cerebellum.
    Maura G; Guadagnin A; Raiteri M
    Neuroscience; 1995 Sep; 68(2):455-63. PubMed ID: 7477956
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of the serotonin1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans.
    Werhahn KJ; Förderreuther S; Straube A
    Neurology; 1998 Sep; 51(3):896-8. PubMed ID: 9748054
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of ovalbumin-induced allergic rhinitis by sumatriptan through the nitric oxide pathway in mice.
    Hemmati S; Rahimi N; Dabiri S; Alaeddini M; Etemad-Moghadam S; Dehpour AR
    Life Sci; 2019 Nov; 236():116901. PubMed ID: 31610206
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Measuring event-related potentials.
    Dixon R
    Cephalalgia; 1999 Jul; 19 Suppl 24():29-30; discussion 30-1. PubMed ID: 10526680
    [No Abstract]   [Full Text] [Related]  

  • 78. Nmda alters the development of hypoxic pulmonary vasoconstriction and nitric oxide synthetase activity in the isolated perfused rat lung.
    Polak MJ; Xiao S; Ashton CA; Baylis C
    Exp Lung Res; 2002; 28(3):251-63. PubMed ID: 11936777
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
    Deleu D; Hanssens Y
    J Clin Pharmacol; 2000 Jul; 40(7):687-700. PubMed ID: 10883409
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity?
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropharmacology; 2001 Mar; 40(4):520-5. PubMed ID: 11249961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.